FIELD: organic synthesis. SUBSTANCE: invention provides two new crystalline forms (S and T) of known compound identified by X-ray diffraction spectra of powders. These forms are pharmaceutically useful in treatment of patients with positive HIV reaction. EFFECT: extended choice of anti- AIDS drugs. 2 cl, 8 ex
Authors
Dates
1999-09-10—Published
1995-03-01—Filed